TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL

被引：0
|
作者：
Ahluwalia, M. S. [1 ,2 ]
Khosla, A. A. [1 ,2 ]
Ozair, A. [1 ]
Kotecha, R. R. [1 ,2 ]
McDermott, M. W. [1 ,2 ]
Mehta, M. P. [1 ,2 ]
Sandoval-Leon, A. C. [1 ]
Mahtani, R. [1 ,2 ]
Peereboom, D. M. [3 ]
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad137.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
JS06.5.A
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL
    Ahluwalia, Manmeet
    Ozair, Ahmad
    Khosla, Atulya
    Bellur, Shreyas
    Kotecha, Rupesh
    McDermott, Michael
    Mehta, Minesh
    Sandoval-Leon, Ana
    Mahtani, Reshma
    Peereboom, David
    NEURO-ONCOLOGY, 2023, 25
  • [2] TUTOR: A MULTICENTER, PHASE 1 TRIAL OF TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER
    Ahluwalia, M. S.
    Ozair, A.
    Bardhan, M.
    Bellur, S. S.
    Perche, D. C.
    Starosciak, A. K.
    Khosla, A. A.
    Leon-Ariza, D. S.
    Rubens, M.
    Odia, Y.
    Mehta, M. P.
    Kotecha, R. R.
    McDermott, M. W.
    Leon, A. C. S.
    Mahtani, R.
    Peereboom, D. M.
    NEURO-ONCOLOGY, 2024, 26 : V47 - V47
  • [3] A MULTICENTER PHASE 1 TRIAL OF TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER2 POSITIVE BREAST CANCER (TUTOR)
    Ahluwalia, Manmeet
    Ozair, Ahmad
    Bardhan, Mainak
    Bellur, Shreyas
    Starosciak, Amy
    Perche, Dilanis
    Khosla, Atulya
    Leon-Ariza, Daniel
    Rubens, Muni
    Odia, Yazmin
    Mehta, Minesh
    Kotecha, Rupesh
    Mcdermott, Michael
    Sandoval-Leon, Ana
    Mahtani, Reshma
    Peereboom, David
    NEURO-ONCOLOGY, 2024, 26
  • [4] TP A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2-positive breast cancer (TUTOR)
    Ahluwalia, Manmeet Singh
    Ozair, Ahmad
    Bardhan, Mainak
    Bellur, Shreyas S.
    Perche, Dilanis C.
    Starosciak, Amy K.
    Leon-Ariza, Daniel S.
    Khosla, Atulya Aman
    Rubens, Muni
    Odia, Yazmin
    Mehta, Minesh P.
    Kotecha, Rupesh
    McDermott, Michael W.
    Sandoval-Leon, Ana Cristina
    Mahtani, Reshma L.
    Peereboom, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases
    Khatri, Vaseem M.
    Mills, Matthew N.
    Oliver, Daniel E.
    Yu, Hsiang-Hsuan Michael
    Vogelbaum, Michael A.
    Forsyth, Peter A.
    Soliman, Hatem H.
    Han, Hyo S.
    Ahmed, Kamran A.
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (1) : 191 - 197
  • [6] Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases
    Vaseem M. Khatri
    Matthew N. Mills
    Daniel E. Oliver
    Hsiang-Hsuan Michael Yu
    Michael A. Vogelbaum
    Peter A. Forsyth
    Hatem H. Soliman
    Hyo S. Han
    Kamran A. Ahmed
    Journal of Neuro-Oncology, 2023, 164 : 191 - 197
  • [7] Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases
    Mo, Dun-Chang
    Luo, Peng-Hui
    Huang, Jian-Feng
    JAMA ONCOLOGY, 2023, 9 (07) : 1008 - 1009
  • [8] Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
    Murthy, R. K.
    Loi, S.
    Okines, A.
    Paplomata, E.
    Hamilton, E.
    Hurvitz, S. A.
    Lin, N. U.
    Borges, V.
    Abramson, V.
    Anders, C.
    Bedard, P. L.
    Oliveira, M.
    Jakobsen, E.
    Bachelot, T.
    Shachar, S. S.
    Mueller, V.
    Braga, S.
    Duhoux, F. P.
    Greil, R.
    Cameron, D.
    Carey, L. A.
    Curigliano, G.
    Gelmon, K.
    Hortobagyi, G.
    Krop, I.
    Loibl, S.
    Pegram, M.
    Slamon, D.
    Palanca-Wessels, M. C.
    Walker, L.
    Feng, W.
    Winer, E. P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (07): : 597 - 609
  • [9] Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases
    Metzger Filho, O.
    Leone, J. P.
    Li, T.
    Tan-Wasielewski, Z.
    Trippa, L.
    Barry, W. T.
    Younger, J.
    Lawler, E.
    Walker, L.
    Freedman, R. A.
    Tolaney, S. M.
    Krop, I
    Winer, E. P.
    Lin, N. U.
    ANNALS OF ONCOLOGY, 2020, 31 (09) : 1231 - 1239
  • [10] Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
    Lin, Nancy U.
    Borges, Virginia
    Anders, Carey
    Murthy, Rashmi K.
    Paplomata, Elisavet
    Hamilton, Erika
    Hurvitz, Sara
    Loi, Sherene
    Okines, Alicia
    Abramson, Vandana
    Bedard, Philippe L.
    Oliveira, Mafalda
    Mueller, Volkmar
    Zelnak, Amelia
    DiGiovanna, Michael P.
    Bachelot, Thomas
    Chien, A. Jo
    O'Regan, Ruth
    Wardley, Andrew
    Conlin, Alison
    Cameron, David
    Carey, Lisa
    Curigliano, Giuseppe
    Gelmon, Karen
    Loibl, Sibylle
    Mayor, JoAl
    McGoldrick, Suzanne
    An, Xuebei
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (23) : 2610 - +
12345